New hope for lymphoma patients: drug may keep cancer in check
Disease control
Not yet recruiting
This study tests a drug called chidamide in people with a fast-growing type of lymphoma (double-expressor DLBCL) who are in remission but still have tiny traces of cancer DNA in their blood. The goal is to see if taking chidamide for up to 2 years can clear those traces and keep …
Phase: PHASE2 • Sponsor: Rong Tao • Aim: Disease control
Last updated May 16, 2026 10:19 UTC